Descriptive study of patients with bipolar disorder and dyslipidemia

Abstract

Introduction It is known the relationship between mental disorders such as bipolar disorder and metabolic disorders such as dyslipidemia, and therefore, increasing comorbid pathologies such as heart disease. Objectives Determine in patients diagnosed with bipolar disorder and dyslipidemia, which are the epidemiological characteristics, the diagnostic subtype and drug treatment prevalent. Aims Determine the profile of patients with bipolar disorder and dyslipidemia. Methods Creation of a database and conduction of a descriptive study with statistical analysis of the data extracted from the medical records of 100 patients from a public hospital. Results Higher prevalence of diagnosis of bipolar disorder type I on II (74% and 26%), male (54%) over female (46%), the age range of 40–50years, treated with antipsychotics more mood stabilizers (62%) compared to mood stabilizer monotherapy (38%) (Fig. 1). Conclusions Interventions should be conducted screening character and in patients with a diagnosis of bipolar disorder type I, male, age between 30–50years, treated with mood stabilizers plus antipsychotics (with a preference for lithium association with olanzapine).